- Home
- CC vs WGS Comparison
CC vs WGS Comparison
Compare CC & WGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CC
- WGS
- Stock Information
- Founded
- CC 2014
- WGS 2017
- Country
- CC United States
- WGS United States
- Employees
- CC N/A
- WGS N/A
- Industry
- CC Major Chemicals
- WGS Retail: Computer Software & Peripheral Equipment
- Sector
- CC Industrials
- WGS Technology
- Exchange
- CC Nasdaq
- WGS Nasdaq
- Market Cap
- CC 2.1B
- WGS 2.4B
- IPO Year
- CC N/A
- WGS N/A
- Fundamental
- Price
- CC $17.17
- WGS $127.92
- Analyst Decision
- CC Buy
- WGS Strong Buy
- Analyst Count
- CC 8
- WGS 7
- Target Price
- CC $17.25
- WGS $102.14
- AVG Volume (30 Days)
- CC 3.0M
- WGS 558.5K
- Earning Date
- CC 11-03-2025
- WGS 10-28-2025
- Dividend Yield
- CC 2.03%
- WGS N/A
- EPS Growth
- CC N/A
- WGS N/A
- EPS
- CC N/A
- WGS 0.05
- Revenue
- CC $5,850,000,000.00
- WGS $362,321,000.00
- Revenue This Year
- CC $5.12
- WGS $35.84
- Revenue Next Year
- CC $4.79
- WGS $18.46
- P/E Ratio
- CC N/A
- WGS $2,638.92
- Revenue Growth
- CC 0.62
- WGS 48.70
- 52 Week Low
- CC $9.13
- WGS $35.88
- 52 Week High
- CC $22.38
- WGS $136.00
- Technical
- Relative Strength Index (RSI)
- CC 68.51
- WGS 59.36
- Support Level
- CC $16.26
- WGS $118.27
- Resistance Level
- CC $17.76
- WGS $129.25
- Average True Range (ATR)
- CC 0.72
- WGS 5.47
- MACD
- CC 0.09
- WGS -1.72
- Stochastic Oscillator
- CC 73.49
- WGS 54.43
About CC Chemours Company (The)
The Chemours Co is a provider of chemicals. It delivers customized solutions with a wide range of industrial and specialty chemicals products for various markets including coatings, plastics, refrigeration, air conditioning, etc. The company's operating segments include Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. It generates maximum revenue from the Titanium Technologies segment. The Titanium Technologies segment is a producer of TiO2 pigment, a premium white pigment used to deliver whiteness, brightness, opacity, durability, efficiency, and protection across a variety of applications. Geographically, the company derives a majority of its revenue from North America.
About WGS GeneDx Holdings Corp.
GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. The company is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.